We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
+7.55%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$17.1B
AUM Growth
-$646M
(-3.6%)
Cap. Flow
-$1.62B
Cap. Flow
% of AUM
-9.46%
Top 10 Holdings %
Top 10 Hldgs %
3.13%
Holding
5,006
New
607
Increased
1,563
Reduced
1,808
Closed
822
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$62M |
| 2 |
Amazon
AMZN
|
+$53.3M |
| 3 |
CVS Health
CVS
|
+$40.3M |
| 4 |
PayPal
PYPL
|
+$34.8M |
| 5 |
McDonald's
MCD
|
+$34.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$56.8M |
| 2 |
EXE
Expand Energy Corp
EXE
|
+$43.4M |
| 3 |
Charter Communications
CHTR
|
+$42.4M |
| 4 |
Comcast
CMCSA
|
+$40.3M |
| 5 |
Mastercard
MA
|
+$37.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.54% |
| 2 | Technology | 11.9% |
| 3 | Consumer Discretionary | 9.76% |
| 4 | Healthcare | 8.91% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
4D Molecular Therapeutics
FDMT
$592M
| $358K | ﹤0.01% |
+16,132
| New | +$249K |
|
|
GRP.U
3252
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $357K | ﹤0.01% |
6,991
-20,046
| -74% | -$1.07M |
|
3253
CALL
Quanta Services
PWR
$101B
| $356K | ﹤0.01% |
2,500
-2,100
| -46% | -$298K |
|
3254
Strategy Inc
MSTR
$37.6B
| $355K | ﹤0.01% |
25,070
+2,370
| +10% | +$48.4K |
|
3255
Gossamer Bio
GOSS
$89.9M
| $355K | ﹤0.01% |
163,399
-348,392
| -68% | -$2.87M |
|
|
DCT
3256
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $354K | ﹤0.01% |
29,368
-80,699
| -73% | -$926K |
|
3257
CALL
Capital One
COF
$135B
| $353K | ﹤0.01% |
3,800
-53,800
| -93% | -$5.29M |
|
3258
Flowserve
FLS
$10.2B
| $353K | ﹤0.01% |
11,503
-109,597
| -91% | -$3.2M |
|
3259
Ezcorp Inc
EZPW
$1.66B
| $352K | ﹤0.01% |
43,145
+10,286
| +31% | +$91.7K |
|
3260
Deluxe
DLX
$1.12B
| $351K | ﹤0.01% |
20,684
-39,958
| -66% | -$711K |
|
3261
PUT
Jones Lang LaSalle
JLL
$16.7B
| $351K | ﹤0.01% |
+2,200
| New | +$351K |
|
3262
CALL
RenaissanceRe
RNR
$13.3B
| $350K | ﹤0.01% |
1,900
| – | – |
|
|
WWE
3263
CALL
DELISTED
World Wrestling Entertainment
WWE
| $349K | ﹤0.01% |
+5,100
| New | +$385K |
|
|
ATXS
3264
DELISTED
Astria Therapeutics
ATXS
| $349K | ﹤0.01% |
23,462
+8,796
| +60% | +$90.7K |
|
3265
Camtek
CAMT
$7.52B
| $349K | ﹤0.01% |
+15,883
| New | +$367K |
|
3266
Aecom
ACM
$8.61B
| $348K | ﹤0.01% |
4,094
-17,863
| -81% | -$1.4M |
|
3267
CALL
Eldorado Gold
EGO
$10.2B
| $347K | ﹤0.01% |
41,500
| – | – |
|
3268
AlTi Global
ALTI
$454M
| $346K | ﹤0.01% |
+31,757
| New | +$317K |
|
3269
EnerSys
ENS
$6.87B
| $346K | ﹤0.01% |
4,689
-5,247
| -53% | -$366K |
|
|
EBACU
3270
DELISTED
European Biotech Acquisition Corp. Units
EBACU
| $346K | ﹤0.01% |
34,367
-14,790
| -30% | -$148K |
|
3271
CALL
Marriott International
MAR
$90.9B
| $342K | ﹤0.01% |
2,300
-1,600
| -41% | -$246K |
|
|
BSAQ.U
3272
DELISTED
Black Spade Acquisition Co Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
BSAQ.U
| $342K | ﹤0.01% |
34,151
+4,507
| +15% | +$44.8K |
|
3273
Noodles & Co
NDLS
$95.1M
| $341K | ﹤0.01% |
7,775
+6,060
| +353% | +$266K |
|
3274
Ovintiv
OVV
$17.6B
| $341K | ﹤0.01% |
6,722
-222,715
| -97% | -$11.6M |
|
|
MAGN
3275
Magnera Corp
MAGN
$442M
| $341K | ﹤0.01% |
9,430
-6,708
| -42% | -$274K |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q4 2022 Portfolio in Review
As of Q4 2022, Cubist Systematic Strategies held 5,006 positions worth $17.1B, down 3.6% from $17.8B the previous quarter. Its ten largest holdings account for 3.1% of the portfolio.
Cubist Systematic Strategies withdrew a net $1.62B in Q4 2022, closing 822 positions and reducing 1,808 holdings. Its most notable exit was Edison International, an estimated $25.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Cubist Systematic Strategies opened a new position in Bristol-Myers Squibb worth $30.8M.
- Cubist Systematic Strategies's largest Q4 2022 buy was Bristol-Myers Squibb: 428,476 shares worth $30.8M.
- Cubist Systematic Strategies added most to Apple in Q4 2022, an estimated $62M increase.
- Cubist Systematic Strategies's biggest Q4 2022 reduction was Visa, cutting an estimated $56.8M.
- Cubist Systematic Strategies fully exited Edison International in Q4 2022, selling an estimated $25.2M.
- Cubist Systematic Strategies's ten largest holdings make up 3.1% of its $17.1B portfolio in Q4 2022.
- Cubist Systematic Strategies opened 607 new positions and closed 822 in Q4 2022.
- Cubist Systematic Strategies's portfolio value fell 3.6% quarter-over-quarter to $17.1B.
Based on Cubist Systematic Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.